Sustainable pipeline of innovative immunotherapies.


Transforming drug discovery and development through single-cell analytics.

Publications and Presentations

Pioneering scientific research and corporate strategy.

HiFiBiO Therapeutics is a pioneer of novel antibody drug discovery and development by leveraging single-cell analytics to treat cancer, autoimmune and infectious disorders. We are applying our innovative Drug Intelligence Science (DIS®) technology towards discovering stratification biomarkers to match high-quality therapeutics with each and every patient.